Cargando…
Successful management of in-transit cutaneous squamous cell carcinoma with anti-PD-1 immunotherapy
This report describes the case of a 70-year-old man with metastatic squamous cell carcinoma (SCC) of the right lower leg. Soon after definitive surgical management of the primary and nodal metastases with curative intent, he relapsed, developing aggressive in-transit metastatic disease and recurrent...
Autores principales: | Furkert, Chris, Martin, Richard, Sharma, Avinash, Rivalland, Gareth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503120/ https://www.ncbi.nlm.nih.gov/pubmed/37715254 http://dx.doi.org/10.1186/s12957-023-03179-3 |
Ejemplares similares
-
Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2021) -
Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy
por: Ishitsuka, Yosuke, et al.
Publicado: (2021) -
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
por: Boutros, Andrea, et al.
Publicado: (2021) -
The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023) -
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Aboul-Fettouh, Nader, et al.
Publicado: (2021)